期刊文献+
共找到925篇文章
< 1 2 47 >
每页显示 20 50 100
Study on the Mechanism of Mahuang Xixin Fuzi Decoction in Treating AR and Prediction of Its Q-Markers Based on Network Pharmacology and Molecular Docking
1
作者 Lingli Cao Xiaomin Chen +1 位作者 Yun Guo Yinman Feng 《Chinese Medicine and Natural Products》 2025年第2期115-123,共9页
Objective This study aimed to investigate the potentialmechanism of Mahuang Xixin Fuzi Decoction in treating allergic rhinitis(AR)and predict its quality markers(Q-markers)using network pharmacology and molecular dock... Objective This study aimed to investigate the potentialmechanism of Mahuang Xixin Fuzi Decoction in treating allergic rhinitis(AR)and predict its quality markers(Q-markers)using network pharmacology and molecular docking techniques.Methods The chemical components of the herbal constituents in Mahuang Xixin Fuzi Decoction were retrieved from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP).Active component-related targets were screened using the SwissTargetPrediction database,while AR-related targets were obtained from the GeneCards database.The intersection targets(potential therapeutic targets of the Mahuang Xixin Fuzi Decoction for AR)were identified via the Venn 2.1.0 platform,and a Venn diagram was constructed.A“herb–active component–potential target”network was established using Cytoscape 3.10.0,and core components were screened via topological analysis.Protein–protein interaction(PPI)network of the intersection targets was built using the String database,followed by topological analysis to identify core targets.Gene Ontology(GO)enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway analysis were performed on the core targets using the DAVID database.Molecular docking of core components and targets was conducted using AutoDock Tools 1.5.7.Results Twenty-seven active components were identified from TCMSP,with 506 corresponding targets predicted by SwissTargetPrediction.A total of 2,447 AR-related targets were retrieved from GeneCards,yielding 165 intersection targets.Network analysis revealed naringenin,genkwanin,deoxyandrographolide,karakoline,and karanjin as core components.PPI network analysis identified 32 core targets.GO enrichment analysis screened 834 functional items,including 618 biological processes,72 cellular components,and 144 molecular functions.KEGG analysis identified 165 signaling pathways.Molecular docking confirmed stable binding between core components and key targets.Conclusion Multiple chemical components in Mahuang Xixin Fuzi Decoction may ameliorate AR by regulating diverse targets and biological processes.Naringenin,genkwanin,and deoxyandrographolide are proposed as potential Q-markers for this decoction in AR treatment. 展开更多
关键词 allergic rhinitis mahuang Xixin Fuzi Decoction Q-markers network pharmacology molecular docking
原文传递
Mechanism of improving skin barrier function in a mouse model of atopic dermatitis using Mahuang Lianqiao Chixiaodou decoction and its disassembled formula 被引量:4
2
作者 Jingang Liu Yan Sun +7 位作者 Huimin Yuan Yuda Li Jing Feng Yushan Gao Yang Tang Shujing Zhang Hang Wang Fengjie Zheng 《Journal of Traditional Chinese Medical Sciences》 2021年第4期309-316,共8页
Objective: To reveal the mechanism of Mahuang Lianqiao Chixiaodou decoction and its disassembled formula for improving the skin barrier function in a mouse model of atopic dermatitis(AD).Methods: Sixty specific-pathog... Objective: To reveal the mechanism of Mahuang Lianqiao Chixiaodou decoction and its disassembled formula for improving the skin barrier function in a mouse model of atopic dermatitis(AD).Methods: Sixty specific-pathogen free male BALB/c mice were randomly divided into the control group,model group, whole formula group(WF), exterior-releasing formula group(ERF), interior-clearing formula group(ICF), and positive control group(PC). A mouse model of AD was established using the semiantigen 2,4-dinitrofluorobenzene induction method. The lesion scores, transepidermal water loss and p H, and skin histopathology of mice in each group were observed. The expressions of filaggrin, loricrin,and involucrin were detected by the streptavidin peroxidase immunohistochemical method and western blotting, and their mRNA expressions were detected by quantitative polymerase chain reaction.Results: Mice in the WF, ERF, ICF, and PC groups showed reduced skin lesion performance, improved histopathology, decreased skin lesion score, transepidermal water loss and pH, and upregulated expressions of proteins including filaggrin, loricrin, and involucrin, and their mRNAs. The most obvious regulatory effect was observed in the WF group, followed by the ICF, ERF, and PC groups, accordingly.Conclusions: Mahuang Lianqiao Chixiaodou decoction and its disassembled formula can improve the skin barrier function in a mouse model of AD by upregulating filaggrin, loricrin, and involucrin, and their mRNA expressions, and the most optimal effect was noted in the WF group, followed by the ICF and ERF groups, which suggests that the effect of clearing heat and resolving dampness in improving the skin barrier function of AD is more obvious and is one of the key treatments for AD. 展开更多
关键词 Atopic dermatitis mahuang Lianqiao Chixiaodou decoction Correspondence between pattern and formula elements Skin barrier
暂未订购
Intervention of the Mahuang Lianqiao Chixiaodou decoction on immune imbalance in atopic dermatitis-like model mice 被引量:1
3
作者 Huimin Yuan Yan Sun +7 位作者 Yang Tang Yuxin Zhang Shuangqiao Liu Jingang Liu Shujing Zhang Yushan Gao Jing Feng Fengjie Zheng 《Journal of Traditional Chinese Medical Sciences》 CAS 2022年第4期392-399,共8页
Objective:To explore the potential mechanism of intervention on the immune imbalance of atopic dermatitis(AD) by studying the effects of Mahuang Lianqiao Chixiaodou decoction(MLCD) on skin damage and inflammation fact... Objective:To explore the potential mechanism of intervention on the immune imbalance of atopic dermatitis(AD) by studying the effects of Mahuang Lianqiao Chixiaodou decoction(MLCD) on skin damage and inflammation factors in an AD-like mouse model.Methods:Ninety-six male BALB/c mice were divided into normal,model,positive control(mometasone furoate),and traditional Chinese medicine treatment(MLCD) groups by a random number table.2,4-dinitrofluorobenzene was used to induce AD-like mice in all groups except the normal group.The treatment or intervention was administered for seven consecutive days on days 4,18,32,and 39.The mRNA relative expressions of interleukin-4(IL-4),IL-10,interferon-γ(IFN-γ),thymic stromal lymphopoietin(TSLP),and the TSLP receptor(TSLPR) were measured using quantitative real-time polymerase chain reaction,and the serum immunoglobulin E,IL-4,IL-10,and IFN-γ levels were detected using enzyme-linked immunosorbent assay.Results:Compared with the normal group,the hematoxylin-eosin staining of the skin lesions of the mice in the model group was significantly thickened on days 11,25,and 39.Compared with the model group,the epidermal thickness of the positive control group was significantly alleviated on day 39(P <.001),and that of the MLCD group was significantly improved on days 25 and 39(P <.001).Compared with the four observation time points,MLCD had the best treatment effect on day 39 of the experiment and significantly improved the skin damage performance and relieved pathological lesions.On day 39,compared with the model group,MLCD downregulated the skin mRNA relative expressions of IL-4(P=.009),TSLP(P=.030),and TSLPR(P <.001),and reduced the mouse serum levels of IL-4(P=.003).For other serum indicators,no significant difference was observed between the model and MLCD groups.Conclusion:MLCD improved AD-like mice skin damage by regulating the Th1/Th2 immune imbalance. 展开更多
关键词 Atopic dermatitis mahuang Lianqiao Chixiaodou decoction Immune imbalance Inflammation factors
暂未订购
Efficacy and safety of Mahuang Fuzi Xixin Decoction on sick sinus syndrome: Ameta – analysis 被引量:1
4
作者 Bo Liang Wei-Lin Liang Hui-Ling Liao 《TMR Integrative Medicine》 2018年第1期30-38,共9页
Objective: To evaluate the efficacy and safety of Mahuang Fuzi Xixin Decoction on sick sinus syndrome andprovide evidence for clinical practice. Methods: Randomized controlled trials of all the languages of MahuangF... Objective: To evaluate the efficacy and safety of Mahuang Fuzi Xixin Decoction on sick sinus syndrome andprovide evidence for clinical practice. Methods: Randomized controlled trials of all the languages of MahuangFuzi Xixin Decoction on sick sinus syndrome were collected by computer search and manual retrieval. Theretrieval time was from January 2000 to January 2017. According to the inclusion and exclusion criteria, 2reviewers independently selected and extracted data, then evaluated the quality, cross-checked the information andevaluated the quality of menthodology. Through discussion or third reviewer to help solve the divergence, RevMan5.3 software was used to perform meta analysis. Results: A total of 7 documents (n = 612) were finally enrolled,with 358 in Mahuang Fuzi Xixin Decoction group (treatment group) and 254 in control group. Meta analysisshowed that the treatment (86.9%) was more effective than the control (70.1%), the difference was statisticallysignificant (RR = 1.25, 95% CI:(1.15-1.37), P 〈 0.001); the treatment (17.0%) was safer than the control (49.8%),the difference was statistically significant (RR=0.23,95% CI:(0.06-0.93), P =0.04). Conclusion: The existingclinical studies suggest that Mahuang Fuzi Xixin Decoction on sick sinus syndrome is effective and safe; due to thelimited quality of the enrolled documents, the above conclusions need more high-quality randomized controlledtrials to be verified. 展开更多
关键词 mahuang Fuzi Xixin Decoction Sick sinus syndrome Meta - analysis
暂未订购
Mahuang Xixin Fuzi decoction protects against ovalbumin-induced allergic rhinitis by inhibiting type 2 innate lymphoid cells in mice
5
作者 Hong Ren Wenting Ji +4 位作者 Xue Yu Dongyu Ge Ruijuan Dong Qingguo Wang Min Liu 《Journal of Traditional Chinese Medical Sciences》 2019年第4期331-336,共6页
Objective:As a traditional herbal formula,Mahuang Xixin Fuzi decoction(MXFD)has been used to treat allergic rhinitis(AR).It regulates the transcription factor GATA3 in T cells,blocks Th2 skewing and rebalances the Th1... Objective:As a traditional herbal formula,Mahuang Xixin Fuzi decoction(MXFD)has been used to treat allergic rhinitis(AR).It regulates the transcription factor GATA3 in T cells,blocks Th2 skewing and rebalances the Th1/Th2 immunity.Type 2 innate lymphoid cells(ILC2s)are closely associated with GATA3.However,it remains unknown whether ILC2s could be one mechanism through which MXFD acts.We sought to elucidate the efficacy and mechanism of action of this decoction in AR treatment.Methods:Forty C57BL/6J female mice were equally divided into control,model,loratadine-and MXFDtreated groups in random.AR was induced by ovalbumin(OVA),and then treatment with loratadine or MXFD was administered.AR scores were evaluated and compared before and after treatment.Pathological changes in the nasal mucosa and lung were observed using hematoxylin-eosin staining of tissue samples.Activation of ILC2 in nasal mucosa was assessed by immunofluorescence and quantitative polymerase chain reaction analysis.ILC2 cell count in lungs was measured by flow cytometry and levels of interleukin-(IL)4,IL-5 and IL-13 in serum were detected by ELISA.Results:The decoction alleviated the symptoms of AR in mice,improved vascular congestion and expansion,glandular hyperplasia and inflammatory cell infiltration in mouse nasal mucosa and slowly improved the interstitial pneumonia and lesions.Meanwhile,MXFD reduced the number and percentage of ILC2s in the nasal mucosa and lungs,downregulated the expression of GATA3 mRNA and RORa mRNA,and reduced the related inflammatory cytokine levels,including IL-4,IL-5 and IL-13.Conclusion:These data suggest that inhibition of ILC2s by MXFD may be an important means by which to treat AR. 展开更多
关键词 mahuang Xixin Fuzi decoction Allergic rhinitis Type 2 innate lymphoid cells
暂未订购
Research on the Preparation Process of Mahuang Xixin Fuzi Decoction Granules
6
作者 Lingli Cao Congying Wang Yinman Feng 《Chinese Medicine and Natural Products》 2024年第4期153-160,共8页
Objective The objective of this study was to investigate the preparation process of Mahuang Xixin Fuzi decoction granules based on the clinical pharmacological effects of the classic formulas and to control the qualit... Objective The objective of this study was to investigate the preparation process of Mahuang Xixin Fuzi decoction granules based on the clinical pharmacological effects of the classic formulas and to control the quality of the product.Methods An orthogonal experimental design was used,with extraction yield and transfer rate of key ingredients as evaluation indicators,to optimize the extraction process ofMahuang Xixin Fuzi decoction.The granulation process was optimized based on indicators such as granule formation rate,dissolution rate,and moisture absorption rate.Results The optimal extraction process for Mahuang Xixin Fuzi decoction was determined as the following:using 10 times the amount of water to soak for 30 minutes,extracting three times,each for 60minutes,with a concentrated extract relative density of 1.3 g/mL.A mixture of dextrin and starch at a 1:2 ratio was used as a binder for wet granulation.The granule formation rate,dissolution time,and dilution rate of three repeated batches showed relative standard deviation(RSD)values of 1.48,2.83,and 1.55%.Conclusion This method is stable and feasible,providing valuable data for the industrial production of Mahuang Xixin Fuzi decoction granules and further research on this formulation. 展开更多
关键词 mahuang Xixin Fuzi decoction GRANULES preparation process Zhang Zhongjing Treatise on Cold Damage(Shang Han Lun)
原文传递
Analysis of the Curative Effect of Shegan Mahuang Decoction Combined with Acupoint Application in the Treatment of Acute Exacerbation of Bronchial Asthma in Children
7
作者 BUXiaohui 《外文科技期刊数据库(文摘版)医药卫生》 2022年第6期027-031,共5页
Objective: to apply the combined therapy of shegan mahuang decoction and acupoint application in the treatment of acute exacerbation of bronchial asthma in children. Methods: the children with acute exacerbation of br... Objective: to apply the combined therapy of shegan mahuang decoction and acupoint application in the treatment of acute exacerbation of bronchial asthma in children. Methods: the children with acute exacerbation of bronchial asthma who were treated in our hospital from January 2021 to January 2022 were selected as the research subjects, and the effects of different treatments were compared, including shegan mahuang decoction and acupoint application + shegan mahuang decoction. Results: after the effective treatment plan was implemented, the condition improved, especially the children treated with acupoint application + shegan mahuang decoction had a higher total effective rate, a lower incidence of adverse reactions, a good trend in FVC and other levels, and symptoms and signs. The scores were lower, and the children who received acupoint application treatment were relatively poor, and the difference was significant (P<0.05). Conclusion: in the treatment of acute exacerbation of bronchial asthma in children, shegan mahuang decoction combined with acupoint application has obvious application value and high safety, and plays a positive role in further shortening the course of the disease in children. 展开更多
关键词 shegan mahuang decoction acupoint application acute exacerbation of bronchial asthma in children
暂未订购
基于CiteSpace的麻黄细辛附子汤研究热点与趋势的可视化分析
8
作者 刘江腾 阮智超 +3 位作者 郭志卂 唐莹 赵进喜 张华 《中国医院用药评价与分析》 2026年第2期160-164,共5页
目的:基于CiteSpace,探讨麻黄细辛附子汤的研究现状、最新热点与前沿趋势。方法:收集中国知网、万方数据库、维普数据库中与麻黄细辛附子汤相关的文献(检索日期为2000年1月1日至2025年8月31日),按照纳入与排除标准筛选后,运用Excel(2021... 目的:基于CiteSpace,探讨麻黄细辛附子汤的研究现状、最新热点与前沿趋势。方法:收集中国知网、万方数据库、维普数据库中与麻黄细辛附子汤相关的文献(检索日期为2000年1月1日至2025年8月31日),按照纳入与排除标准筛选后,运用Excel(2021)和CiteSpace(6.3.1)软件对发文量、作者、机构和关键词等进行图谱绘制。结果:共纳入835篇文献,其中《河南中医》为发文量最高的期刊;容蓉和杨勇为发文最多的作者,山东中医药大学为发文最多的机构;麻黄细辛附子汤、变应性鼻炎、缓慢性心律失常等为高频关键词。关键词聚类分析主要集中在麻黄细辛附子汤加味、变应性鼻炎、支气管哮喘、网络药理学等方面,突现分析以病态窦房结综合征的强度和程度最高。结论:麻黄细辛附子汤研究内容广泛,涉及药学研究、多种病证的临床研究和经验总结等方面,网络药理学、作用机制、名医经验为持续研究热点。各团队之间应加强合作,在有效经验和临床应用的基础上,开展实验研究,阐释其作用机制。 展开更多
关键词 麻黄细辛附子汤 CITESPACE 文献计量学 可视化
暂未订购
Study on the Complex Prescription Compatibility Law of the Cold and Hot Nature of Mahuang Decoction(麻黄汤) and Its Categorized Formulae Based on the Cold-Hot Pad Differentiating Assay 被引量:1
9
作者 贾雷 赵艳玲 +5 位作者 王伽伯 邹文俊 李瑞生 杨宏博 程丹红 肖小河 《Chinese Journal of Integrative Medicine》 SCIE CAS 2011年第4期290-295,共6页
Objective:To explore the complex prescription compatibility law of the cold and hot nature of Mahuang Decoction(麻黄汤,MHD) and Maxing Shigan Decoction(麻杏石甘汤,MXSGD),both categorized formulas but with differe... Objective:To explore the complex prescription compatibility law of the cold and hot nature of Mahuang Decoction(麻黄汤,MHD) and Maxing Shigan Decoction(麻杏石甘汤,MXSGD),both categorized formulas but with different hot/cold natures.Methods:Oxygen consumption of mice was determined among three groups:MHD,MXSGD and the control;a cold-hot pad differentiating assay was used to observe the variability of temperature tropism among the groups of mice which was treated with MHD,MXSGD,and their compositions. Meanwhile,the total anti-oxidant capability(T-AOC) activity were detected.Results:After administration of MHD, the mice showed increased oxygen consumption(P0.01).Compared with MHD group,the remaining rate of MXSGD mice on the hot pad was found to be significantly increased with the cold-hot pad differentiating assay (P0.05).There was no significant difference(P0.05) among the remaining rates of MXSGD,MXSGD with high dose Gypsum Fibrosum(MXHGF) group,and MXSGD with low dose Gypsum Fibrosum(MXLGF) group mice.Compared with the MHD group,T-AOC activity of the mice in the Consensus Compositons group was significantly decreased(P=0.0494).Compared with the MXSGD group,T-AOC activity of Gypsum Fibrosum (GF) group was increased significantly(P=0.0013).Conclusions:The differences in cold and hot nature could be represented objectively between MHD with a hot nature and MXSGD with a cold nature.The reason may be the Gypsum Fibrosum which decreased the efficacy of the consensus compositions.However,increasing or decreasing the dose of Gypsum Fibrosum will not change the cold and hot nature of MXSGD. 展开更多
关键词 mahuang Decoction and its categorized formulae cold and hot nature of Chinese drugs complex prescription compatibility law of Chinese medicine cold-hot pad differentiating assay
原文传递
麻黄治疗荨麻疹临床应用及机制研究
10
作者 林胜 王晓旭 +2 位作者 谢耀萱 徐静 张广中 《辽宁中医药大学学报》 2026年第3期57-61,共5页
荨麻疹作为临床常见的局限性水肿性皮肤疾病,其发病与超敏、炎症反应等生理病理过程密切相关。麻黄作为中医治疗荨麻疹的常用药,具有疏风透疹、宣肺利水的功效,现代研究进一步揭示其多成分、多靶点的药效特征。该文系统综述了麻黄治疗... 荨麻疹作为临床常见的局限性水肿性皮肤疾病,其发病与超敏、炎症反应等生理病理过程密切相关。麻黄作为中医治疗荨麻疹的常用药,具有疏风透疹、宣肺利水的功效,现代研究进一步揭示其多成分、多靶点的药效特征。该文系统综述了麻黄治疗荨麻疹的古今应用脉络,整合其生物碱类、黄酮类及挥发油等活性物质的相关研究进展,重点探讨其在治疗荨麻疹方面抗过敏、免疫抑制、抗炎等核心作用机制。通过整合药理机制与临床证据,进行系统的梳理与综述,旨在为麻黄在不同复方中针对荨麻疹的药效及其作用机制以及基于有效性合理评价麻黄资源提供理论基础,以促进麻黄治疗荨麻疹的现代化研究进程。 展开更多
关键词 麻黄 荨麻疹 超敏反应 临床应用 机制探讨
原文传递
刘丽坤运用麻黄升麻汤治疗鼻咽癌经验
11
作者 周博雯 李梦华 +1 位作者 李晓丽 刘丽坤(指导) 《山东中医杂志》 2026年第2期190-193,212,共5页
总结刘丽坤教授运用麻黄升麻汤治疗鼻咽癌的经验。认为本病以气阴两虚为本,痰瘀热毒为标,治疗重点在于益气养阴扶正的同时,兼顾祛痰、瘀、热、毒之病理因素。根据临床经验认为麻黄升麻汤寒热并用、补虚清实之功正契合鼻咽癌之病机。临... 总结刘丽坤教授运用麻黄升麻汤治疗鼻咽癌的经验。认为本病以气阴两虚为本,痰瘀热毒为标,治疗重点在于益气养阴扶正的同时,兼顾祛痰、瘀、热、毒之病理因素。根据临床经验认为麻黄升麻汤寒热并用、补虚清实之功正契合鼻咽癌之病机。临证以麻黄升麻汤为基础治疗鼻咽癌,依据患者虚实之侧重,调整方中清热与温中药物比例,根据患者邪气郁闭之程度,巧用麻黄剂量。依据临床症状,分经论治,各药用量随证加减,共达宣通郁闭、寒热同调、补虚清实、标本同治之功效。并附验案1则。 展开更多
关键词 麻黄升麻汤 鼻咽癌 痰瘀热毒 气阴两虚 虚实兼治 寒热并用 分经论治
暂未订购
Different Effects of Mahuang Decoction and Maxing Shigan Decoction on Animal Temperature Tropism and Correlation to Differences of Cold and Hot Nature of Chinese Materia Medica
12
作者 WANG Jia-bo ZHAO Yan-ing +5 位作者 ZHANG Xue-ru ZHOU Can-ping LIU Ta-si ZHAO Hai-ping REN Yong-shen XIAO Xiao-he 《Chinese Herbal Medicines》 CAS 2010年第3期211-215,243,共5页
Objective To establish an objective method for evaluating the intrinsic characteristics between cold and hot nature of Chinese materia medica(CMM)through the different effects of Mahuang decoction(MHD)and Maxing Shiga... Objective To establish an objective method for evaluating the intrinsic characteristics between cold and hot nature of Chinese materia medica(CMM)through the different effects of Mahuang decoction(MHD)and Maxing Shigan decoction(MSD)on animal temperature tropism.Methods The equipment with cold/hot pads was used to investigate the variety of the temperature tropism between two groups of mice treated by MHD and MSD,respectively.Meanwhile,the activities of adenosine triphosphatase(ATPase),superoxide dismutase,succinate dehydrogenase,and malondialdehyde were measured.Results After treated by MHD,the macroscopic behavioral index of remaining rate on warm pad(40℃)of mice decreased significantly(P<0.05),suggesting the enhancement of cold tropism,meanwhile,the internal indices of ATPase activity and oxygen consuming volume increased significantly(P<0.05),suggesting the enhancement of energy metabolism.On the other hand,the above-mentioned indices in MSD group changed on the inverse way.Conclusion The relative drug nature of MHD and MSD revealed in this study is consistent with the theoretical prognostication or definition.It indicates that the internal cold and hot nature of CMM could be reflected in ethological way on the changes of animal temperature tropism which might be internally regulated by body energy metabolism. 展开更多
关键词 cold/hot nature of Chinese materia medica mahuang decoction Maxing Shigan decoction temperature tropism
原文传递
CHEMISTRY AND BIOACTIVITY OF POLYSACCHARIDES FROM TRADITIONAL CHINESE MEDICINE MAHUANG
13
作者 Yong-Gang Xia Bing-You Yang Hai-Xue Kuang 《World Journal of Traditional Chinese Medicine》 2015年第4期82-83,共2页
The long-term clinical practice of traditional Chinese medicine(TCM)confirms its importance and essential role in the health care system in China,especially in the prevention and treatment of chronic diseases.TCM is t... The long-term clinical practice of traditional Chinese medicine(TCM)confirms its importance and essential role in the health care system in China,especially in the prevention and treatment of chronic diseases.TCM is the holistic medicine under the guidance of system theory,emphasizing harmony between human and nature,focusing on equilibrium and balance,and focusing on 展开更多
关键词 TCM CHEMISTRY AND BIOACTIVITY OF POLYSACCHARIDES FROM TRADITIONAL CHINESE MEDICINE mahuang
原文传递
麻黄附子甘草汤辅助治疗冠心病的效果观察
14
作者 曲永红 石萍杰 《华夏医学》 2026年第1期110-115,共6页
目的观察麻黄附子甘草汤辅助治疗冠心病的效果。方法选取125例冠心病患者按照随机数字表法分为常规组62例,辅助组63例。常规组实施常规药物治疗,辅助组采用麻黄附子甘草汤辅助治疗,治疗后均随访1年。比较两组的炎症指标、心肌损伤标志... 目的观察麻黄附子甘草汤辅助治疗冠心病的效果。方法选取125例冠心病患者按照随机数字表法分为常规组62例,辅助组63例。常规组实施常规药物治疗,辅助组采用麻黄附子甘草汤辅助治疗,治疗后均随访1年。比较两组的炎症指标、心肌损伤标志物、主要不良心血管事件(MACE)发生情况以及心功能指标。结果不同治疗方案下,辅助组的基质外金属蛋白酶-9(MMP-9)、半胱天冬酶-3(CASP-3)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)均低于常规组,差异有统计学意义(P<0.05)。辅助组的肌红蛋白(MYO)、心肌肌钙蛋白(cTnT)、肌酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)均低于常规组(P<0.05)。随访期间,辅助组的MACE发生率低于常规组(P<0.05)。随访结束时,辅助组的LVEF、CO均高于常规组,LVEDV、LVESV均低于常规组(P<0.05)。结论麻黄附子甘草汤辅助治疗冠心病能减轻患者炎症反应及心肌损伤,对降低患者MACE发生风险并促进心功能恢复均有积极影响。 展开更多
关键词 冠心病 麻黄附子甘草汤 炎症反应 心肌损伤 心功能
暂未订购
《神农本草经》与经方应用之麻黄篇
15
作者 彭雪 张岱泽 +1 位作者 白湘玉 袁红霞 《山东中医药大学学报》 2026年第1期42-46,91,共6页
麻黄是经方常用药物之一,《神农本草经》描述其功效为“主中风伤寒头痛,温疟发表出汗,去邪热气,止咳逆上气,除寒热,破癥坚积聚”。《伤寒杂病论》以《神农本草经》中麻黄功效为基础,进行药物配伍形成短小精炼的经典方剂,至今仍有深刻影... 麻黄是经方常用药物之一,《神农本草经》描述其功效为“主中风伤寒头痛,温疟发表出汗,去邪热气,止咳逆上气,除寒热,破癥坚积聚”。《伤寒杂病论》以《神农本草经》中麻黄功效为基础,进行药物配伍形成短小精炼的经典方剂,至今仍有深刻影响。如麻黄“主中风伤寒头痛”,多配伍桂枝、苦杏仁、葛根、石膏,以麻黄汤、葛根汤、大青龙汤为代表方;主“温疟发表出汗,去邪热气”,多配伍桂枝、芍药、石膏,以桂枝二越婢一汤为代表方;主“止咳逆上气,除寒热”,多配伍射干、石膏、半夏、细辛、五味子,以小青龙加石膏汤、射干麻黄汤、越婢加半夏汤、麻黄杏仁甘草石膏汤等为代表方;主“破癥坚积聚”,多配伍桂枝,附子,芍药,以桂枝芍药知母汤、乌头汤为代表方。张仲景在继承《神农本草经》麻黄功效的同时进行发展与创新,如利水消肿。应用麻黄时应互参《神农本草经》及《伤寒杂病论》。 展开更多
关键词 《神农本草经》 《伤寒杂病论》 麻黄 中风伤寒头痛 温疟 止咳逆上气 破癥坚积聚
暂未订购
麻黄汤的方药用量和临证体会 被引量:4
16
作者 何永明 李志鹏 +2 位作者 许楠 程赟 周玟 《中华中医药学刊》 北大核心 2025年第4期193-196,共4页
麻黄汤首见于《伤寒杂病论》,方药由麻黄、桂枝、杏仁、甘草组成,主治外感风寒表实证,典型方证为:恶寒无汗、头疼身痛、脉浮紧。麻黄去根节,无需去茎节。桂枝、肉桂可单用也可合用。光杏仁用时捣碎,药力易煮出。《伤寒论》中炙甘草可能... 麻黄汤首见于《伤寒杂病论》,方药由麻黄、桂枝、杏仁、甘草组成,主治外感风寒表实证,典型方证为:恶寒无汗、头疼身痛、脉浮紧。麻黄去根节,无需去茎节。桂枝、肉桂可单用也可合用。光杏仁用时捣碎,药力易煮出。《伤寒论》中炙甘草可能是现代中药饮片生甘草。麻黄汤原方的剂量折算当是:一两约为15.6 g。然而,麻黄量大易致心慌、大汗、失眠等不良反应。若一两按5 g折算,则剂量为:麻黄15 g,桂枝10 g,杏仁7.5 g,甘草5 g,亦可发汗解表。麻黄汤治疗风寒感冒,可加减化裁,大人、小儿、妇女、老人皆可用。药证相对、方证相应,掌握麻黄汤方证和量效关系,是安全有效使用麻黄汤的关键。 展开更多
关键词 麻黄汤 方证 剂量
原文传递
麻黄附子细辛汤联合非免疫抑制治疗对脾肾阳虚型局灶节段性肾小球硬化患者的临床疗效
17
作者 姚天文 韩世盛 +2 位作者 苏哲苓 徐艳秋 王怡 《中成药》 北大核心 2025年第7期2238-2242,共5页
目的考察麻黄附子细辛汤联合非免疫抑制治疗对脾肾阳虚型局灶节段性肾小球硬化患者的临床疗效。方法60例患者随机分为对照组和观察组,每组30例,对照组给予非免疫抑制治疗,观察组在对照组基础上加用麻黄附子细辛汤,疗程24周。检测临床疗... 目的考察麻黄附子细辛汤联合非免疫抑制治疗对脾肾阳虚型局灶节段性肾小球硬化患者的临床疗效。方法60例患者随机分为对照组和观察组,每组30例,对照组给予非免疫抑制治疗,观察组在对照组基础上加用麻黄附子细辛汤,疗程24周。检测临床疗效、中医证候疗效、中医证候评分、24 h UTP、ALB、eGFR、Nephrin、Podocin、安全性指标变化。结果观察组总有效率、中医证候有效率高于对照组(P<0.05)。治疗后,2组中医证候评分、24 h UTP、Nephrin、Podocin降低(P<0.05),ALB升高(P<0.05),以观察组更明显(P<0.05)。2组未发生明显不良反应。结论麻黄附子细辛汤联合非免疫抑制治疗可安全有效地改善脾肾阳虚型局灶节段性肾小球硬化患者中医证候,其作用机制可能与缓解足细胞损伤有关。 展开更多
关键词 麻黄附子细辛汤 非免疫抑制治疗 局灶节段性肾小球硬化 脾肾阳虚 中医证候 足细胞损伤
暂未订购
TRPA1离子通道在慢性气道炎症性疾病中的作用及中药干预研究进展
18
作者 方芳 郭媛琦 +4 位作者 顾媛媛 蒙艳丽 郭玉岩 左军 龙宇 《时珍国医国药》 北大核心 2025年第14期2748-2753,共6页
慢性气道炎症性疾病是一种累及气道的炎症性疾病,其发病机制尚未明确。近年来研究表明,TRPA1离子通道在慢性气道炎症性疾病的发生发展和治疗中起着重要作用,是治疗慢性气道炎症性疾病的潜在靶点,中药治疗可通过调控TRPA1离子通道抑制氧... 慢性气道炎症性疾病是一种累及气道的炎症性疾病,其发病机制尚未明确。近年来研究表明,TRPA1离子通道在慢性气道炎症性疾病的发生发展和治疗中起着重要作用,是治疗慢性气道炎症性疾病的潜在靶点,中药治疗可通过调控TRPA1离子通道抑制氧化应激、组织损伤和炎症反应,进而缓解慢性气道炎症性疾病的症状。文章对TRPA1离子通道在慢性气道炎症性疾病中的作用机制和中药调控TRPA1离子通道治疗慢性气道炎症性疾病的研究进展进行综述,以期为中药治疗慢性气道炎症性疾病的应用提供理论参考。 展开更多
关键词 TRPA1 慢性气道炎症 三拗汤 止嗽散 厚朴麻黄汤 苓桂术甘汤
原文传递
麻黄连翘赤小豆汤治疗湿疹风寒外束、湿热蕴肤型
19
作者 赵冰 刘爱民 王庆兴 《吉林中医药》 2025年第5期574-577,共4页
目的 探讨麻黄连翘赤小豆汤治疗湿疹风寒外束、湿热蕴肤型患者临床疗效。方法 选择湿疹风寒外束、湿热蕴肤型患者96例,按照简单随机数字表法分为对照组与观察组,各48例。对照组使用曲安奈德益康唑乳膏联合依巴斯汀治疗,观察组在对照组... 目的 探讨麻黄连翘赤小豆汤治疗湿疹风寒外束、湿热蕴肤型患者临床疗效。方法 选择湿疹风寒外束、湿热蕴肤型患者96例,按照简单随机数字表法分为对照组与观察组,各48例。对照组使用曲安奈德益康唑乳膏联合依巴斯汀治疗,观察组在对照组基础上加用麻黄连翘赤小豆汤治疗。评估2组临床疗效和症状积分,比较2组外周血干扰素γ(IFN-γ)、白细胞介素-4(IL-4)水平及特异性转录因子T-bet、GATA结合蛋白3(GATA-3)表达变化情况。结果 观察组临床疗效总有效率(95.83%,46/48)高于对照组(83.33%,40/48)(P<0.05)。治疗后,观察组单项症状评分、外周血IL-4水平、T-bet/GATA-3低于对照组(P<0.05),外周血IFN-γ水平、GATA-3高于对照组(P<0.05)。结论 麻黄连翘赤小豆汤可明显提高湿疹风寒外束、湿热蕴肤型患者临床疗效,缓解临床症状,改善辅助性T细胞1(Th1)/辅助性T细胞2(Th2)失衡。 展开更多
关键词 湿疹 风寒外束 湿热蕴肤 麻黄连翘赤小豆汤
暂未订购
麻黄连翘赤小豆汤及其效应成分抑制IgA肾病大鼠替代途径补体激活的研究 被引量:2
20
作者 宋婷 盛广宇 +2 位作者 阮伟 张亚亨 杨雪军 《中国中药杂志》 北大核心 2025年第6期1626-1636,共11页
探究麻黄连翘赤小豆汤(MHLQ)及其主要效应成分治疗IgA肾病(IgAN)的可能作用机制。采用牛血清白蛋白(BSA)灌胃、皮下注射四氯化碳(CCl4)、尾静脉注射脂多糖(LPS)等综合措施建立IgAN大鼠模型。成模后,将IgAN大鼠随机分为模型组,MHLQ低、... 探究麻黄连翘赤小豆汤(MHLQ)及其主要效应成分治疗IgA肾病(IgAN)的可能作用机制。采用牛血清白蛋白(BSA)灌胃、皮下注射四氯化碳(CCl4)、尾静脉注射脂多糖(LPS)等综合措施建立IgAN大鼠模型。成模后,将IgAN大鼠随机分为模型组,MHLQ低、中、高剂量组,连翘苷(PHI)组,盐酸伪麻黄碱(PSE)组及氯沙坦钾(LP)组,并以Wistar大鼠为对照。MHLQ低、中、高剂量组分别给予MHLQ颗粒剂1.773、3.545、7.090 g·kg^(-1)灌胃,PHI组给予PHI 0.020 g·kg^(-1)灌胃,PSE组给予PSE 0.020 g·kg^(-1)灌胃,LP组给予LP 9.003 mg·kg^(-1)灌胃,对照组和模型组每日灌胃等体积生理盐水,各组均连续干预4周。给药结束后收集各组大鼠尿液、血清、肝组织和肾组织。检测24 h尿蛋白定量(24 h UTP)和肾功能;病理染色观察肾组织病理改变;免疫荧光(IF)检测肾脏IgA和补体C3/C3b/C3c表达;电镜观察肾组织超微结构;酶联免疫吸附测定(ELISA)法检测血清和肾组织补体C3、可溶性端补体复合物(sC5b-9)蛋白表达;蛋白免疫印迹(Western blot)法检测肝、肾补体C3/C3b/C3c、C5/C5a、C5b-9及B因子(CFB)蛋白表达;免疫组化(IHC)进一步检测肾组织补体C3蛋白表达。结果显示,与对照组比较,模型组大鼠尿素氮(BUN)、血肌酐(SCr)含量升高,肾小球代偿性扩张,球内系膜细胞增殖,系膜基质扩张,肾小球可见IgA免疫复合物或电子致密物沉积;血清补体C3含量增加;肾组织CFB,补体C3/C3b/C3c、C5/C5a、C5b-9蛋白表达升高;肝组织中补体C3/C3b/C3c和C5b-9蛋白表达升高。而经过MHLQ及其效应成分干预后,上述指标皆逆转。综上所述,MHLQ及其效应成分干预IgAN大鼠疗效肯定,能够改善肾功能,减轻肾脏免疫复合物沉积和病理损伤,其机制可能与抑制IgAN大鼠替代途径(AP)补体激活有关。 展开更多
关键词 麻黄连翘赤小豆汤 IGA肾病 补体激活 炎症反应 补体C3
原文传递
上一页 1 2 47 下一页 到第
使用帮助 返回顶部